Tenax Therapeutics (TENX) Intangibles (2011 - 2017)
Tenax Therapeutics (TENX) reported Intangibles of $22.0 million for Q2 2017, little changed on a YoY basis from $22.0 million in Q2 2016, and little changed sequentially from $22.0 million in Q3 2016.
Tenax Therapeutics (TENX) Intangibles (2011 - 2017) Analysis & Trends
Tenax Therapeutics (TENX) has 7 years of Intangibles data on file, last reported at $22.0 million in Q2 2017.
- For the quarter ending Q2 2017, Intangibles changed 0.0% year-over-year to $22.0 million; the trailing twelve-month figure through Jun 2017 stood at $22.0 million (changed 0.0% YoY), and the FY2015 full-year result was $23.5 million, up 2535.43% from the prior year.
- Intangibles steadied at $22.0 million in Q2 2017, from $22.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $23.5 million in Q2 2015 to a low of $893358.0 in Q2 2014.
- A 5-year average of $13.2 million and a median of $22.0 million in 2016 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slipped 3.39% in 2014 and jumped 2535.43% in 2015, its largest moves.
- Tracing TENX's Intangibles over 5 years: stood at $924698.0 in 2013, then retreated by 3.39% to $893358.0 in 2014, then jumped by 2535.43% to $23.5 million in 2015, then fell by 6.56% to $22.0 million in 2016, then changed by 0.0% to $22.0 million in 2017.
- Business Quant data shows TENX's Intangibles at $22.0 million in Q2 2017, $22.0 million in Q3 2016, and $22.0 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 22.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | 22.00 Mn |
| Apr 30, 2015 | 23.54 Mn |
| Apr 30, 2014 | 893,358.00 |
| Apr 30, 2013 | 924,698.00 |
| Jan 31, 2013 | 923,397.00 |
| Oct 31, 2012 | 904,498.00 |
| Jul 31, 2012 | 881,317.00 |
| Apr 30, 2012 | 872,971.00 |
| Jan 31, 2012 | 863,510.00 |
| Oct 31, 2011 | 831,407.00 |
| Jul 31, 2011 | 746,033.00 |
| Apr 30, 2011 | 699,951.00 |